When can osimertinib be started as adjuvant therapy after chemotherapy?

When you can start using osimertinib (osimertinib mesylate) as adjuvant therapy after chemotherapy depends mainly on the patient's specific situation and the doctor's recommendations.

For patients with lung cancer, it is recommended to start taking osimertinib one week after completing chemotherapy. This time window is to give the body time to fully recover while ensuring an effective connection between chemotherapy and targeted therapy. However, this time is not absolutely fixed and needs to be determined based on the patient's physical condition and the doctor's advice.

In the famous ADAAURA trial, patients with non-small cell lung cancer who underwent complete tumor resection were required to start osimertinib adjuvant treatment within 10 weeks after surgery if they did not receive adjuvant chemotherapy; if they received adjuvant chemotherapy, they were required to start within 26 weeks after surgery. The setting of this time window is based on clinical trial data and aims to ensure that patients receive osimertinib treatment at the optimal time to obtain the greatest survival benefit.

It is important to note that each patient's specific situation is unique and therefore the timing of initiating adjuvant osimertinib therapy should also be considered on an individual basis. Doctors will develop the most appropriate treatment plan based on factors such as the patient's pathological type, stage, physical condition, chemotherapy regimen, and EGFR mutation status. In some cases, doctors may directly recommend osimertinib as an adjuvant treatment option if a patient cannot tolerate or refuses chemotherapy.

After starting osimertinib adjuvant therapy, patients should closely monitor their physical condition and treatment effects, and communicate with their doctors regularly. The doctor will adjust the treatment plan according to the patient's specific situation and treatment effect, including the dosage and frequency of the drug and whether it needs to be combined with other treatments.